Stay up-to-date with our latest news, blog articles, videos, and event announcements. Learn from business success stories and gain access to valuable e-books and resources.
The pharmaceutical industry is always evolving and advancing, and the world of sterile filling is no exception. Here at Adragos, steriles are one of our core competencies, and we keep a keen interest in how the market is progressing to […]
Patients rely on pharmaceutical manufacturers to ensure that the medicines they are given are safe. For injectable products, aseptic filling is key, and facilities such as Adragos Jura must follow regulatory guidelines extremely carefully. The product must be totally protected […]
Recently, Konstantinos Apostolou, R&D senior manager at our Athens Development facility, was featured in European Pharmaceutical Manufacturer, where he explored the rapid rise of highly potent active pharmaceutical ingredients (HPAPIs). The market is valued at $185.5 billion in 2024 and […]
Annex 1 to EU GMP for sterile products came into effect in 2023, and while technically it is for the EU, in practice it has rapidly become a worldwide standard. It has brought in a number of additional formal requirements […]
In the ever-evolving pharmaceutical landscape, non-sterile liquid solutions have emerged as one of the most adaptable and efficient dosage forms available today. Unlike sterile preparations, these formulations do not require aseptic manufacturing conditions, yet they must maintain an exceptionally high […]
At Adragos Jura, ensuring pharmaceutical quality is central to our mission of delivering medicines that are safe, effective, and consistently reliable. Even minor lapses could impact product quality and efficacy, which is why authorities such as Swissmedic, FDA, and EMA […]
Get notified on our latest news.
